Citation: M. Delgado et D. Ganea, Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo, J IMMUNOL, 167(2), 2001, pp. 966-975
Citation: M. Delgado et D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of fas ligand in activated T lymphocytes by regulating c-myc, NF-kappa B, NF-AT, and early growth factors 2/3, J IMMUNOL, 166(2), 2001, pp. 1028-1040
Citation: M. Delgado et D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1, J BIOL CHEM, 276(1), 2001, pp. 369-380
Authors:
Kim, WK
Kan, YQ
Ganea, D
Hart, RP
Gozes, I
Jonakait, GM
Citation: Wk. Kim et al., Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway, J NEUROSC, 20(10), 2000, pp. 3622-3630
Citation: M. Delgado et D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages, J NEUROIMM, 110(1-2), 2000, pp. 97-105
Citation: Hy. Wang et al., The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells, J NEUROIMM, 104(1), 2000, pp. 68-78
Citation: M. Delgado et D. Ganea, Inhibition of IFN-gamma-induced Janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide, J IMMUNOL, 165(6), 2000, pp. 3051-3057
Citation: M. Delgado et D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting fas ligand expression, J IMMUNOL, 165(1), 2000, pp. 114-123
Citation: M. Delgado et D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression, J IMMUNOL, 164(3), 2000, pp. 1200-1210
Authors:
Wang, HY
Jiang, XM
Gozes, I
Fridkin, M
Brenneman, DE
Ganea, D
Citation: Hy. Wang et al., Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms, REGUL PEPT, 84(1-3), 1999, pp. 55-67
Authors:
Delgado, M
Leceta, J
Abad, C
Martinez, C
Ganea, D
Gomariz, RP
Citation: M. Delgado et al., Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide, J NEUROIMM, 99(1), 1999, pp. 61-71
Authors:
Delgado, M
Munoz-Elias, EJ
Gomariz, RP
Ganea, D
Citation: M. Delgado et al., VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFN gamma synthesis by T cells, J NEUROIMM, 96(2), 1999, pp. 167-181
Citation: M. Delgado et al., VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression, J IMMUNOL, 163(8), 1999, pp. 4213-4223
Authors:
Delgado, M
Leceta, J
Gomariz, RP
Ganea, D
Citation: M. Delgado et al., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression, J IMMUNOL, 163(7), 1999, pp. 3629-3635
Authors:
Delgado, M
Munoz-Elias, EJ
Gomariz, RP
Ganea, D
Citation: M. Delgado et al., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation, J IMMUNOL, 162(8), 1999, pp. 4685-4696
Authors:
Delgado, M
Pozo, D
Martinez, C
Leceta, J
Calvo, JR
Ganea, D
Gomariz, RP
Citation: M. Delgado et al., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: In vitro and in vivo studies, J IMMUNOL, 162(4), 1999, pp. 2358-2367
Authors:
Delgado, M
Munoz-Elias, EJ
Gomariz, RP
Ganea, D
Citation: M. Delgado et al., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: In vitro and in vivo studies, J IMMUNOL, 162(3), 1999, pp. 1707-1716
Authors:
Delgado, M
Martinez, C
Pozo, D
Calvo, JR
Leceta, J
Ganea, D
Gomariz, RP
Citation: M. Delgado et al., Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6, J IMMUNOL, 162(2), 1999, pp. 1200-1205
Citation: M. Delgado et D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappa B and Ets activation, J BIOL CHEM, 274(45), 1999, pp. 31930-31940